Clindamycin Pharmacokinetics and Safety in Preterm and Term Infants

about

Improving Pediatric Protein Binding Estimates: An Evaluation of α1-Acid Glycoprotein Maturation in Healthy and Infected Subjects.Dosing antibiotics in neonates: review of the pharmacokinetic data.Pharmacokinetics of Clindamycin in Obese and Nonobese Children.

P2860

Q38639379-F46F6ACE-719C-47B3-BD98-D4D3D58A39F3 Q38649419-D0FDFF85-E4BB-4A98-B78E-CE2C3094E28F Q38991202-907D34AA-E56A-490B-B526-5057E25D07EF

P2860

Clindamycin Pharmacokinetics and Safety in Preterm and Term Infants

Item

http://www.wikidata.org/entity/Q36887756

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Clindamycin Pharmacokinetics and Safety in Preterm and Term Infants

@en

type

Item

label

Clindamycin Pharmacokinetics and Safety in Preterm and Term Infants

@en

prefLabel

Clindamycin Pharmacokinetics and Safety in Preterm and Term Infants

@en

P1476

Clindamycin Pharmacokinetics and Safety in Preterm and Term Infants

@en

P2093

Barry T Bloom

http://www.w3.org/2001/XMLSchema#string

Brenda B Poindexter

http://www.w3.org/2001/XMLSchema#string

C Michael Cotten

http://www.w3.org/2001/XMLSchema#string

Daniel K Benjamin

http://www.w3.org/2001/XMLSchema#string

Elisabeth McGowan

http://www.w3.org/2001/XMLSchema#string

Karen Shattuck

http://www.w3.org/2001/XMLSchema#string

Kathleen K Bradford

http://www.w3.org/2001/XMLSchema#string

Matthew M Laughon

http://www.w3.org/2001/XMLSchema#string

Maurine Morris

http://www.w3.org/2001/XMLSchema#string

Michael Cohen-Wolkowiez

http://www.w3.org/2001/XMLSchema#string

P2860

Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescents

Perl-speaks-NONMEM (PsN)--a Perl module for NONMEM related programming.

Influence of human serum on pharmacodynamic properties of an investigational glycopeptide, LY333328, and comparator agents against Staphylococcus aureus.

Penetration of clindamycin and its metabolite N-demethylclindamycin into cerebrospinal fluid following intravenous infusion of clindamycin phosphate in patients with AIDS.

Medication use in the neonatal intensive care unit

Lopinavir/ritonavir population pharmacokinetics in neonates and infants.

Methicillin-resistant and susceptible Staphylococcus aureus bacteremia and meningitis in preterm infants

Features of invasive staphylococcal disease in neonates.

Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitis.

Protein binding predictions in infants

P304

2888-2894

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.03086-15

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Daniel Gonzalez

P577

2016-02-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26926644

http://www.w3.org/2001/XMLSchema#string

P921

preterm infant

P932

4862454

http://www.w3.org/2001/XMLSchema#string

Clindamycin Pharmacokinetics and Safety in Preterm and Term Infants

about

P2860

P2860

Clindamycin Pharmacokinetics and Safety in Preterm and Term Infants

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932